Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood...
Undergraduate students in Washington State University’s College of Veterinary Medicine helped power the research behind a recent Nature publication that found humans share key skin structures...
The purpose of this study was to enhance the current knowledge of the relationship between the gut microbiome and osteoarthritis (OA) and associated pain using pet dogs as a clinically relevant...
Feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) is a rare and poorly understood disease characterised by the infiltration of eosinophils and the development of fibrous tissue...
Antimicrobial resistance (AMR) is one of the main health concerns worldwide and addressing the problem through the One Health approach is essential to manage the burden of AMR emergence and...
Veterinary33 previews NAVC Institute 2026, a veterinary education event scheduled for 2026, with attention to clinical learning, professional development, an...
Veterinary33 previews VMX 2026, a major veterinary event scheduled for 2026, with attention to clinical education, innovation, and business opportunities for...
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion...
The AQUAVET® I program provides valuable hands-on experience in aquatic veterinary medicine to fill a critical gap in traditional veterinary curricula.
Lameness due to musculoskeletal disease is the most common diagnosis in equine veterinary practice. Many of these orthopaedic disorders are chronic problems, for which no clinically satisfactory...
